What's new

Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised

Jun 24, 2025 - 17:50
 0
Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

EMEA-003535-PIP02-24

Next Article

NATO chief to Europe: ‘Stop worrying’ about US, just increase spending

Related Posts

Orphan designation: Parahydroxybenzoic acid Treatment of primary ubiquinone deficiency, 16/04/2025 Positive

Orphan designation: Parahydroxybenzoic acid Treatment o...

Jun 10, 2025  0

Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

Veterinary medicines European public assessment report (EPAR): Bravecto CombiUNO, fluralaner,milbemycin oxime, Status: Opinion

Veterinary medicines European public assessment report ...

Jun 13, 2025  0